https://www.selleckchem.com/pr....oducts/Thiazovivin.h
The five-year overall survival for patients in whom an R0 resection of both primary and metastatic disease was achieved was 54.6% compared with 20% for those with an R1/R2 resection(p=0.006). CONCLUSION Simultaneous pelvic exenteration and liver resection is feasible, with acceptable morbidity and mortality. Simultaneous resection should only be performed where an R0 resection of both pelvic and hepatic disease is anticipated. This article is protected by copyright. All rights reserved.Metagenomics is a tool that enables researchers
Curtir
Comentario
Compartilhar
